Bio-Rad Laboratories BIO
NYSE BIO
$376.41 +12.15 (+3.34%)
At close: Aug 20, 2026 · 4:00 PM EDT

Bio-Rad Laboratories (BIO) Change in Accured Expenses (2009 - 2017)

Bio-Rad Laboratories (BIO) posted quarterly Change in Accured Expenses of $5.0 million for Q3 2017, down 82.01% year-over-year from $27.9 million in Q3 2016, and down 86.43% quarter-over-quarter from $37.0 million in Q2 2017.

Bio-Rad Laboratories (BIO) Change in Accured Expenses (2009 - 2017) Analysis & Trends

Bio-Rad Laboratories (BIO) has reported Change in Accured Expenses for 9 consecutive years, with $5.0 million the latest figure, recorded in Q3 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn -
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 298.00 Mn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 123.00 Mn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 234.00 Mn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn 123.70 Mn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn 112.90 Mn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 19.00 Mn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 43.01 Mn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 4.80 Mn
10 Bio-Rad Laboratories 10.08 Bn 8.46 Bn 345.80 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2017 5.02 Mn
Sep 30, 2017 5.02 Mn
Jun 30, 2017 37.00 Mn
Jun 30, 2017 37.00 Mn
Mar 31, 2017 -61.16 Mn
Mar 31, 2017 -61.16 Mn
Sep 30, 2016 27.92 Mn
Sep 30, 2016 27.92 Mn
Jun 30, 2016 15.10 Mn
Jun 30, 2016 15.10 Mn
Mar 31, 2016 -47.67 Mn
Mar 31, 2016 -47.67 Mn
Sep 30, 2015 40.97 Mn
Sep 30, 2015 40.97 Mn
Jun 30, 2015 -15.36 Mn
Jun 30, 2015 -15.36 Mn
Mar 31, 2015 -7.75 Mn
Mar 31, 2015 -7.75 Mn
Sep 30, 2014 40.75 Mn
Sep 30, 2014 40.75 Mn